Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial.
Fiche publication
Date publication
juin 2019
Journal
Annals of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LEPAGE Côme, Dr VERNEREY Dewi
Tous les auteurs :
Bruzzi M, Auclin E, Lo Dico R, Voron T, Karoui M, Espin E, Cianchi F, Weitz J, Buggenhout A, Malafosse R, Denimal F, Le Malicot K, Vernerey D, Douard R, Emile JF, Lepage C, Laurent-Puig P, Taieb J
Lien Pubmed
Résumé
Recurrence patterns in stage III colon cancer (CC) patients according to molecular markers remain unclear. The objective of the study was to assess recurrence patterns according to microsatellite instability (MSI), RAS and BRAF status in stage III CC patients.
Référence
Ann. Surg. Oncol.. 2019 Jun 17;: